CD34(+) stem cells from umbilical cord blood
- PMID: 24765340
- PMCID: PMC3981355
- DOI: 10.4081/cp.2011.e79
CD34(+) stem cells from umbilical cord blood
Abstract
We describe the relation between umbilical cord clamping time and two different enrichment system of CD34(+) stem cells from umbilical cord blood with the proliferative ability and bone marrow reconstitution of the stem cells obtained. After an obstetrician performed the cord blood collection, the purification of stem cells was performed either with a combination of monoclonal antibodies (negative selections) using the Stem Sep method, or with a positive cells selection based on their surface CD34 antigens using the Mini Macs system. An excellent recovery of haematopoietic progenitors [Burst Forming Unit Erythroids (BFUE); Colony Forming Unit Granulocytes and Macrophages (CFU-GM); and Colony Forming Unit Granulocytes, Erythroids, Monocytes and Macrophages (CFU-GME)], inversely related to the increase in clamping time, was performed with the Mini Macs system (54% of colonies, with 90% purity). With Stem Sep method, haematopoietic progenitor's recovery was 35% (with 80% purity). By applying early clamping of umbilical cord blood we obtained a greater number of CD34(+) cells and their clonogenic activity was increased with enrichment. This is a useful technique considering that the number of CD34(+) stem cells usually contained from a unit of placental blood is enough for the transplant to a child, but not for an adult. Thus, using these methods, we can get a larger number of CD34(+) stem cells which reduces the risk of Graft versus Host Disease also in adult patients, producing survival rates similar to those obtained with transplantation of bone marrow from unrelated donors.
Keywords: CD34+ stem cells; enrichment.; recovery; umbilical cord blood.
Figures
Similar articles
-
Two enrichment methods to obtain CD34+ stem cells from umbilical cord blood.Bratisl Lek Listy. 2001;102(4):183-6. Bratisl Lek Listy. 2001. PMID: 11723676
-
Early clamping of umbilical cord blood and foetal CD34 enrichment.Acta Med Austriaca. 2001;28(5):141-4. doi: 10.1046/j.1563-2571.2001.01034.x. Acta Med Austriaca. 2001. PMID: 11774776
-
Two CD34+ stem cells from umbilical cord blood enrichment methods.Pediatr Hematol Oncol. 2002 Jun;19(4):239-45. doi: 10.1080/08880010252899406. Pediatr Hematol Oncol. 2002. PMID: 12051590
-
Positive selection of autologous peripheral blood stem cells.Baillieres Best Pract Res Clin Haematol. 1999 Mar-Jun;12(1-2):71-86. doi: 10.1053/beha.1999.0008. Baillieres Best Pract Res Clin Haematol. 1999. PMID: 11000984 Review.
-
Graft Manipulation.2024 Apr 11. In: Sureda A, Corbacioglu S, Greco R, Kröger N, Carreras E, editors. The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies [Internet]. 8th edition. Cham (CH): Springer; 2024. Chapter 19. 2024 Apr 11. In: Sureda A, Corbacioglu S, Greco R, Kröger N, Carreras E, editors. The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies [Internet]. 8th edition. Cham (CH): Springer; 2024. Chapter 19. PMID: 39437084 Free Books & Documents. Review.
Cited by
-
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System.Mol Ther Methods Clin Dev. 2020 May 4;17:1097-1107. doi: 10.1016/j.omtm.2020.04.027. eCollection 2020 Jun 12. Mol Ther Methods Clin Dev. 2020. PMID: 32478125 Free PMC article.
-
Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.Toxins (Basel). 2020 Jun 4;12(6):373. doi: 10.3390/toxins12060373. Toxins (Basel). 2020. PMID: 32512916 Free PMC article. Review.
-
Advances in HIV Gene Therapy.Int J Mol Sci. 2024 Feb 28;25(5):2771. doi: 10.3390/ijms25052771. Int J Mol Sci. 2024. PMID: 38474018 Free PMC article. Review.
-
Evaluation of the Regenerative Potential of Platelet-Lysate and Platelet-Poor Plasma Derived from the Cord Blood Units in Corneal Wound Healing Applications: An In Vitro Comparative Study on Corneal Epithelial Cells.Curr Issues Mol Biol. 2022 Sep 22;44(10):4415-4438. doi: 10.3390/cimb44100303. Curr Issues Mol Biol. 2022. PMID: 36286018 Free PMC article.
-
Umbilical cord blood derived cell expansion: a potential neuroprotective therapy.Stem Cell Res Ther. 2024 Jul 29;15(1):234. doi: 10.1186/s13287-024-03830-0. Stem Cell Res Ther. 2024. PMID: 39075614 Free PMC article. Review.
References
-
- Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanism in stem cell biology. Cell. 1997;88:287–8. - PubMed
-
- Mimiero R, Busca A, Roncarolo MG, et al. HLA-haploidentical umbilical cord blood stem cell transplantation in a child with advanced leukemia: clinical outcome and analysis of hematopoietic recovery. Bone Marrow Transplant. 1995;16:229–40. - PubMed
-
- Katzenstein HM, Morgan ER, Olsewski M, et al. Haploidentical related umbilical cord blood stem cell transplant in a child with acute nonlymphocytic leukemia. Bone Marrow Transplant. 1997;19:765–9. - PubMed
-
- Arcese W, Aversa F, Bandini G, et al. Clinical use of alligeneic hematopoietic stem cell from sources other than bone marrow. Haematologica. 1998;83:159–82. - PubMed
-
- Engelfriet CP, Reesink HW, Wagner JE, et al. Use of cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sang. 1998;75:156–72. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous